After giving up on the cryptocurrency idea, LunaDNA looks to "invert the research equation" by letting patients control and sell their genomic and health information.
LunaDNA parent company LunaPBS will combine its technology platform with Genetic Alliance's PEER system to advance patient-centric research.
The move signals a shift from the startup's original strategy of creating a cryptocurrency to compensate donors of genomic and clinical data.
Luna DNA, which offers a cryptocurrency to reward people for sharing biological and medical data with researchers, has raised $4 million to date.
The newly launched LunaDNA hopes that its community model of compensating individuals for contributing genomic and health information will lead to better research.
LunaDNA is a startup genomic and medical research firm that has created a blockchain-based cryptocurrency to reward people for contributing DNA data.
A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.
South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.
In Science this week: the synthetic genetic system hachimoji, and more.
Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.